MANUEL
DELGADO ALVARADO
Ikertzailea 2022-(e)ra arte
Hospital Universitario de Donostia
San Sebastián, EspañaHospital Universitario de Donostia-ko ikertzaileekin lankidetzan egindako argitalpenak (11)
2021
-
Amyotrophic lateral sclerosis (ALS), cancer, autoimmunity and metabolic disorders: An unsolved tantalizing challenge
British Journal of Pharmacology, Vol. 178, Núm. 6, pp. 1269-1278
-
Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study
Frontiers in Immunology, Vol. 12
2018
-
Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study
Movement Disorders, Vol. 33, Núm. 11, pp. 1809-1813
-
Using Kinect to classify Parkinson's disease stages related to severity of gait impairment
BMC Bioinformatics, Vol. 19, Núm. 1
2017
-
Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study
Movement Disorders, Vol. 32, Núm. 7, pp. 1066-1073
2016
-
Biomarkers for dementia and mild cognitive impairment in Parkinson's disease
Movement Disorders, Vol. 31, Núm. 6, pp. 861-881
2015
-
Cambios en la sustancia gris en pacientes con enfermedad de parkinson y bloqueos de la marcha
Revista de Neurologia
-
Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches
Neuroscience and Biobehavioral Reviews, Vol. 56, pp. 294-314
-
Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene
Journal of the Neurological Sciences, Vol. 350, Núm. 1-2, pp. 93-97
-
The Relationship Between Atrophy and Hypometabolism: Is It Regionally Dependent in Dementias?
Current Neurology and Neuroscience Reports, Vol. 15, Núm. 7
2013
-
Oftalmoplejia completa unilateral sin perdida de vision como forma de presentacion de una apoplejia pituitaria
Revista Clinica Espanola, Vol. 213, Núm. 7